ask="0.1800"
ask_size="6300"
average_daily_volume="1303510"
bid="0.1675"
bid_size="1000"
book_value="0.0730"
change="-0.0035"
change_from_200_day_moving_average="-0.0299"
change_from_50_day_moving_average="0.0077"
change_from_52_week_high="-0.2499"
change_From_52_week_low="0.0401"
change_in_percent="-2.0161%"
close="0.1701"
dividend_pay_date="N/A"
dividend_per_share="N/A"
dividend_yield="N/A"
earnings_per_share="-0.0570"
ebitda="-16.83M"
eps_estimate_current_year="-0.0700"
eps_estimate_next_quarter="-0.0300"
eps_estimate_next_year="-0.1000"
ex_dividend_date="N/A"
float_shares="213764000"
high="0.1736"
high_52_weeks="0.4200"
last_trade_date="2/3/2017"
last_trade_price="0.1701"
last_trade_size="3112"
last_trade_time="4:02pm"
low="0.1672"
low_52_weeks="0.1300"
market_capitalization="40.38M"
moving_average_200_day="0.2000"
moving_average_50_day="0.1624"
name="Rexahn Pharmaceuticals
Inc."
notes="N/A"
one_year_target_price="2.5000"
open="0.1672"
pe_ratio="N/A"
peg_ratio="0.0000"
percent_change_from_200_day_moving_average="-14.9500%"
percent_change_from_50_day_moving_average="+4.7259%"
percent_change_from_52_week_high="-59.5000%"
percent_change_from_52_week_low="+30.8462%"
previous_close="0.1736"
price_eps_estimate_current_year="N/A"
price_eps_Estimate_next_year="N/A"
price_per_book="2.3781"
price_per_sales="N/A"
revenue="N/A"
shares_outstanding="237368000"
short_ratio="1.4700"
stock_exchange="ASE"
symbol="RNN"
volume="705213"
weeks_range_52="0.1300 - 0.4200"
